HLUN-A:CPH
H Lundbeck A/S Class A
45,05 DKK
arrow_upward
+0,33%(+0,15) 1D
16-окт., 17:00:00 GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUN-A...
Open
45,00 DKK
High
45,60 DKK
Low
44,90 DKK
Mkt. cap
47,05 млд
Avg. vol.
100,68 миң
Volume
0,00
52-wk high
45,60 DKK
52-wk low
31,40 DKK
Shares outstanding
199,15 млн
No. of employees
5 миң
Open
45,00 DKK
High
45,60 DKK
Low
44,90 DKK
Mkt. cap
47,05 млд
Avg. vol.
100,68 миң
Volume
0,00
52-wk high
45,60 DKK
52-wk low
31,40 DKK
Shares outstanding
199,15 млн
No. of employees
5 миң
News stories
From web sources and news partners
Simply Wall Street
·
34 мүнөт мурун
Warner Music Group (WMG) Draws Fresh Interest, Is A 17% Discount Still On Offer?
The Motley Fool
·
32 мүнөт мурун
Should You Invest in the S&P 500 Right Now or Wait? There's 1 Clear Answer
Yahoo Finance
·
4 саат мурун
Michael Burry Warns Stock Market Could Be Months Away From A 2000-Style Reckoning — ‘The Preconditions Seem Set For Fireworks’
AOL.com
·
4 саат мурун
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5 миң
Founded1915
Headquarters-
SectorPharmaceutical industry
Websitelundbeck.com